Showing results (191-200 of 266) with videos related to
Sort By:
Pageof 27
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 11, 2002
Eosinophil adhesion to cholinergic nerves via ICAM-1 and VCAM-1 and associated eosinophil degranulationDeborah A Sawatzky, Paul J Kingham, Emma Court, et al.Cancer|January 15, 1980
Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adultsR T Skeel, W Costello, J M Bennett, et al.American Journal of Respiratory Cell and Molecular Biology|July 12, 2003
Effect of eosinophil adhesion on intracellular signaling in cholinergic nerve cellsMarie-Thérèse Walsh, David R Curran, Paul J Kingham, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Eosinophil adhesion to cholinergic IMR-32 cells protects against induced neuronal apoptosisRoss K Morgan, Paul J Kingham, Marie Therese Walsh, et al.Cancer Treatment Reports|April 1, 1982
Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology groupJ H Glick, J M Barnes, R F Bakemeier, et al.Journal of European CME|April 13, 2018
Position paper on current aspects of sponsoring in accredited CMEDaiana Stolz, Reinhard Griebenow, Andre Tichelli, et al.The European Respiratory Journal|March 9, 2019
Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy: results from a systematic literature review and modelling studyMatshediso C Mokoka, Melissa J McDonnell, Elaine MacHale, et al.American Journal of Respiratory and Critical Care Medicine|October 20, 2018
Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe AsthmaLiam G Heaney, John Busby, Peter Bradding, et al.BMJ Open Respiratory Research|September 27, 2022
Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug accessCaroline O'Leary, Christopher Schultz, Cathal Walsh, et al.Annals of Internal Medicine|October 1, 1984
BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group studyR F Bakemeier, J R Anderson, W Costello, et al.Pageof 27